Illinois Tool Works (ITW) Earnings Analysis
Illinois Tool Works (ITW) has no confirmed upcoming earnings date. Last quarter (2026-04-30) it beat with EPS 2.66 USD vs 2.57 USD est (+3.5%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E 25.39.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ITW next report earnings?
No confirmed upcoming earnings date is currently scheduled for ITW. This page updates as the calendar is published.
ITW earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 2.66 USD | 2.57 USD | +3.5% | Beat |
| 2026-02-03 | 2.72 USD | 2.69 USD | +1.1% | Beat |
| 2025-10-24 | 2.81 USD | 2.75 USD | +2.2% | Beat |
| 2025-07-30 | 2.58 USD | 2.56 USD | +0.8% | Beat |
| 2025-04-30 | 2.38 USD | 2.34 USD | +1.7% | Beat |
| 2025-02-05 | 2.54 USD | 2.49 USD | +2% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
ITW valuation and analyst view
| Trailing P/E | 25.39 |
|---|---|
| Trailing EPS | 10.871 USD |
| Price / book | 24.46 |
| Dividend yield | 2.35% |
| Market cap | 79.02B |
| Analyst consensus | Hold (6 buy / 13 hold / 9 sell) |
| Avg price target | 273.6 USD |
Related research pages
Frequently asked questions
When is Illinois Tool Works (ITW)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for ITW. This page updates as the calendar is published.
Did ITW beat earnings last quarter?
In its 2026-04-30 report, ITW posted EPS of 2.66 USD versus a 2.57 USD estimate — a beat of 3.5%.
What is ITW's earnings track record?
Over the last 6 reported quarters with consensus data, ITW beat estimates 6 times (100%).
What is ITW's current P/E ratio and EPS?
ITW trades at a trailing P/E of 25.39 on trailing EPS of 10.870620881026708 USD.
What do analysts rate ITW?
Analyst consensus is "Hold" across 28 ratings (0 strong buy, 6 buy, 13 hold, 9 sell, 0 strong sell). Average 12-month price target: 273.6 USD.